Featured on: Doctor's Guide
Publication date: May 11, 2009
Publication date: May 11, 2009
Research presented at the 2009 Annual Meeting of the Association for Research in Vision and Ophthalmology indicates that long-term vision gains can be achieved in patients with age-related macular degeneration by treatment with anti-vascular endothelial growth factor receptors and maintenance therapy with pegaptanib. The findings are good news for patients at risk of vision loss.
More Vision Articles
Ophthalmologists Can Help Put The 'safety' In Public Safety ForcesJustAnswer And Glaucoma Research Foundation Help Individuals See The Light In Preventing Blindness
Does Your Child Need Vision Therapy?
Saffron Can Protect Against Eyesight Loss
Lots Of Red Meat Can Harm Vision: Report
Anti-Growth Factor Drugs Raise Hope And Concern For Treatment Of Children's Eye
Legally Blind Waitress Serves Cheer, Humor
Vision Is Key To Infant Development
Eat Cantaloupes For Healthy Eyes And Good Vision
Behind The Scenes: Altered Visions
